Nexavar gets FDA nod for thyroid cancer
from dailyRx News
Most thyroid cancers are treatable, even curable. As with most cancers, however, tumors are more difficult to treat once spreading begins. A medication is being evaluated to strengthen the arsenal against advanced thyroid cancer. Nexavar is being fast-tracked for U.S. Food and Drug Administration approval for the treatment of locally advanced or metastatic thyroid cancer that does not respond to radioactive iodine.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063